Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
The cancer access partnership
Prof Richard Sullivan and Emily Kobayashi
The cancer access partnership ( Prof Richard Sullivan and Emily Kobayashi )
6 Oct 2022
The Max foundation: Its mission and contribution to increasing access to cancer ...
Prof Richard Sullivan and Pat Garcia-Gonzalez
The Max foundation: Its mission and contribution to increasing access to cancer medicine ( Prof Richard Sullivan and Pat Garcia-Gonzalez )
6 Oct 2022
Pursuing global equity in access to cancer drugs lessons learned from the HIV ep...
Prof Richard Sullivan and Dr Megan O’Brien
Pursuing global equity in access to cancer drugs lessons learned from the HIV epidemic ( Prof Richard Sullivan and Dr Megan O’Brien )
6 Oct 2022
Access to essential anticancer medicines for children and adolescents
Prof Richard Sullivan and Dr Carlos Rodriguez-Galindo
Access to essential anticancer medicines for children and adolescents ( Prof Richard Sullivan and Dr Carlos Rodriguez-Galindo )
6 Oct 2022
Cancer medicines on the WHO model list of essential medicines: processes, challe...
Prof Richard Sullivan and Dr André Ilbawi
Cancer medicines on the WHO model list of essential medicines: processes, challenges, and a way forward ( Prof Richard Sullivan and Dr André Ilbawi )
6 Oct 2022
ESMO 2022: Lung roundup
Dr Luis Raez - Memorial Cancer Institute, Miami, USA
ESMO 2022: Lung roundup ( Dr Luis Raez -  Memorial Cancer Institute, Miami, USA )
4 Oct 2022
Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unrese...
Prof Jean Bourhis - University Hospital of Lausanne, Lausanne, Switzerland
Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unresected LA SCCHN ( Prof Jean Bourhis - University Hospital of Lausanne, Lausanne, Switzerland )
27 Sep 2022
Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced br...
Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
21 Sep 2022
Defining value based care for LMICs
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Defining value based care for LMICs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
18 Sep 2022
Building collaborations for cancer research
Dr CS Pramesh - Tata Memorial Hospital, Mumbai, India
Building collaborations for cancer research ( Dr CS Pramesh - Tata Memorial Hospital, Mumbai, India )
18 Sep 2022
Defining Value in Indian healthcare: Asking the right questions
Dr Kumar Prabhash - Tata Memorial Hospital, Mumbai, India
Defining Value in Indian healthcare: Asking the right questions ( Dr Kumar Prabhash - Tata Memorial Hospital, Mumbai, India )
18 Sep 2022
ESMO 2022: Breast and ovarian trial analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2022: Breast and ovarian trial analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
14 Sep 2022